Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Zhengye Biotechnology Holding Limited

ZYBTNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.90
$0.002(0.22%)
U.S. Market opens in 10h 47m

Zhengye Biotechnology Holding Limited (ZYBT) Stock Overview

Explore Zhengye Biotechnology Holding Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap41.8M
P/E Ratio0.00
EPS (TTM)$-0.06
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$12.86
3 Months$6.48
1 Year Target$0.00

ZYBT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zhengye Biotechnology Holding Limited (ZYBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 41.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.77%
5-Day Change
1.41%
1-Month Change
-15.18%
3-Month Change
-58.78%
6-Month Change
-87.36%
Year-to-Date (YTD) Change
-21.94%
1-Year Change
-80.09%
3-Year Change
-81.85%
5-Year Change
-81.85%
All-Time (Max) Change
-81.85%

Contact Information

86 432 6304 7008
No.1 Lianmeng Road, Jilin, NaN, 132101

Company Facts

2,780 Employees
IPO DateJan 7, 2025
CountryCN
Actively Trading

Frequently Asked Questions